PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-14.98%
Negative net income growth while BB stands at 28.50%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-0.39%
Both reduce yoy D&A, with BB at -0.58%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-19.43%
Negative yoy deferred tax while BB stands at 20.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
1.26%
Less SBC growth vs. BB's 75.00%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
74.83%
Well above BB's 63.46% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
208.20%
AR growth while BB is negative at -57.47%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-140.19%
Negative yoy inventory while BB is 283.33%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-384.67%
Negative yoy AP while BB is 102.27%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
7.70%
Lower 'other working capital' growth vs. BB's 23.60%. David Dodd would see fewer unexpected short-term demands on cash.
3.43%
Some yoy increase while BB is negative at -15.14%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
120.51%
Operating cash flow growth above 1.5x BB's 61.74%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
6.64%
CapEx growth well above BB's 0.68%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
94.20%
Some acquisitions while BB is negative at -244.44%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-57.66%
Both yoy lines negative, with BB at -69.09%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
43.94%
Below 50% of BB's 199.12%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-240.34%
Both yoy lines negative, with BB at -382.14%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-16.22%
We reduce yoy invests while BB stands at 27.52%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-37.04%
We cut debt repayment yoy while BB is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
20.66%
Issuance growth of 20.66% while BB is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-139.21%
We cut yoy buybacks while BB is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.